Literature DB >> 8826904

The natural history of chronic hepatitis C in haemophiliacs.

M Makris1, F E Preston, F R Rosendaal, J C Underwood, K M Rice, D R Triger.   

Abstract

Most haemophiliacs treated with non-virally-inactivated clotting factor concentrates have been infected with hepatitis C virus (HCV). We have studied the natural history of chronic HCV infection by following all 138 HCV-positive patients from our centre for periods of up to 28 years. As well as the clinical and biochemical characteristics, we studied 116 liver samples from 63 patients obtained at elective biopsy (n = 103) or autopsy (n = 13). 36 (26%) of the patients were HIV positive, and three were chronic carriers of hepatitis B. Evidence of previous exposure to hepatitis A and B was found in 37.2% and 48.1% respectively. Raised transaminase levels were found in 82.6% of patients. 11 of 15 patients with normal transaminases tested by PCR for HCV RNA were positive, indicating that most patients, even in this group, have chronic hepatitis C infection. Cirrhosis was diagnosed by liver histology in 19 patients, and nine patients developed liver failure. The incidence of cirrhosis rose rapidly 15 years after HCV infection to 15.6 per 1000 person-years. Multivariate analysis showed that HIV status, length of time since HCV infection and age at HCV infection were independently associated with both the development of cirrhosis and liver failure. Two patients developed hepatocellular carcinoma: one of these was exposed only to a single batch of FVIII concentrate 11 years earlier. Chronic hepatitis C is increasingly recognized as a major cause for morbidity and mortality in haemophiliacs, especially those who are HIV positive and who were infected at an older age.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826904     DOI: 10.1046/j.1365-2141.1996.02343.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

1.  Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection.

Authors:  Vincent Lo Re; Kevin Haynes; Kimberly A Forde; A Russell Localio; Rita Schinnar; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-09       Impact factor: 2.890

Review 2.  The European Haemophilia Network (EUHANET).

Authors:  Michael Makris; Gabriele Calizzani; Kathelijn Fischer; Alexander Gatt; Estelle Gilman; Robert Hollingsworth; Thierry Lambert; Riitta Lassila; Pier Mannuccio Mannucci; Flora Peyvandi; Jerzy Windyga
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

3.  Outcome of liver transplantation for haemophilia.

Authors:  Satoshi Yokoyama; Adam Bartlett; Faisal S Dar; Michael Heneghan; John O'Grady; Mohamed Rela; Nigel Heaton
Journal:  HPB (Oxford)       Date:  2010-12-01       Impact factor: 3.647

4.  Human leukocyte interferon-alpha treatment for chronic HCV-related hepatitis in hemophilic patients previously intolerant to other interferons-alpha.

Authors:  Luca Dughera; Edda Battaglia; Anna Maria Serra; Daniela Tibaudi; Giuseppina Buonafede; Monica Navino; Piercarla Schinco; Giacomo Tamponi; Giorgio Emanuelli
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

5.  Hepatitis C and HIV-1 coinfection.

Authors:  A H Mohsen; P Easterbrook; C B Taylor; S Norris
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

6.  Acute kidney injury in a diabetic haemophiliac: one step at a time.

Authors:  Mohammed Mahdi Althaf; Maged Hassan Hussein; Mohamed Said Abdelsalam; Sadiq Mohammed Amer
Journal:  BMJ Case Rep       Date:  2014-05-08

7.  Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.

Authors:  Ania Owsianka; Alexander W Tarr; Vicky S Juttla; Dimitri Lavillette; Birke Bartosch; François-Loïc Cosset; Jonathan K Ball; Arvind H Patel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 8.  Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.

Authors:  Miriam Romero; Mayte Pérez-Olmeda; Javier García-Samaniego; Vicente Soriano
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 9.  Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century.

Authors:  Vincent Lo Re; Jay R Kostman; Valerianna K Amorosa
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

10.  Outcome of orthotopic liver transplantation in patients with haemophilia.

Authors:  F H Gordon; P K Mistry; C A Sabin; C A Lee
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.